Skip to content
Checked.be
Complete company report
Generated 14-08-2026
Active BE 0786.721.270Private limited company

Mammoptix

· 4 yrs active
Sector: Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden (32500)
Conclusion Checked

The computed 12-month bankruptcy probability of Mammoptix is 3.9% (moderate). The 2023 annual accounts show negative equity (€-76k) and a net result of €-126k. Its solvency ranks better than 5% of 179 sector peers (fiscal year 2023). The company has been active since 2022 and the Belgian State Gazette contains no insolvency signals. The CBE does carry 1 administrative register entry (see administrative flags).

Based on the State Gazette, CBE and 1 annual account.
Key figures
Equity €-76k
Net result €-126k
Better than sector 5%
Active 4 yrs
Snowflake analysis 4 of 5 axes measured · computed by Checked
Health10Profitability100Solvency33Growth-Stability71
54 / 100

Mixed profile: strong on profitability, weaker on health.

Computed on 4 of 5 axes. Not measured: growth. An unmeasured axis is not a zero: no data was read for it.

Health 10
Profitability 100
Solvency 33
Growth -
Stability 71
Bankruptcy probability (12 mo) Checked model v1 · free
3.9% Moderate
0%0,5%1,5%4%10%≥25%
Annual accounts: weaker financial profile +Young company +Lower-failure-rate sector −

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Risk Assessment rule-based
3 / 100
Low risk
Components
· 1 administrative flag (+3)
Trust signals 1 signals
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags 1 events
Address struck
Health barometer FY 2023 · computed
10 / 100 Critical
050100
Computed from 4 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.

See plans →
Computed by Checked from the NBB filing for FY 2023. Indicative, not credit advice.
Financial overview1 NBB filings
Annual accounts filed on 23-05-2025 with the NBB · fiscal year 2023 · micro
Sector comparison
Fiscal year 2023 · NACE 32 · compared within the same schema type (micro schema)
Metric This company Sector median Position in the sector
Solvency -199.3% 32.5%
better than 5% of 179 sector peers
Net result €-126k €5k
better than 5% of 178 sector peers
Equity €-76k €24k
better than 5% of 179 sector peers
Gross operating margin €-120k €27k
better than 5% of 178 sector peers
Staff costs €159 €38k
higher than 5% of 64 sector peers
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
Fiscal year2023
Depositmicro
Revenue-
EBITDA€-121k
Net profit€-126k
Cash flow€-123k
Staff costs€159
Income taxes-
Dividends-
Total assets€38k
Equity€-76k
Debt€114k
of which ≤ 1y€114k
of which > 1y-
Working capital€-102k
Employees (FTE)-
Ratios (computed)
2023
Current ratio0.10
Quick ratio0.10
Working capital ratio-268.4%
Solvency-199.3%
Debt / equity-1.50
Long-term debt ratio-
Interest coverage-58.26
Gross margin-
Net margin-
ROA-330.7%
ROE165.9%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2023
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2023
Balance sheet, Assets
TOTAL ASSETS 20/58€38k
Fixed assets 21/28€26k
Intangible fixed assets 21€26k
Current assets 29/58€12k
Amounts receivable within one year 40/41€12k
Cash & bank 54/58€8
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€38k
Equity 10/15€-76k
Contributions / capital 10/11€50k
Accumulated profits (losses) 14€-126k
Amounts payable 17/49€114k
Amounts payable within one year 42/48€114k
Trade debts payable within one year 44€34k
Income statement
Gross operating margin 9900€-120k
Operating result 9901€-124k
Financial income 75€7
Financial charges 65€2k
Result before taxes 9903€-126k
Net result for the period 9904€-126k
Result to be appropriated 9905€-126k
Ratios computed by Checked.
Directors & mandates 1 directors
Former directors (1)
  • Geoffrey Ejzenberg
    Director
    State Gazette act 24152023 (22-10-2024)
    Former
    - → 13-09-2024
Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.This list is read straight from this company's published acts, not from the officer register.
Legal Structure
NACE primary Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden(32500)
Legal form Private limited company(610)
Incorporation01-06-2022
StatusActive
Postal code-
Establishment units 1 location
Mammoptix
Vervaardiging van overige farmaceutische producten
since 20222.332.904.438
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Real-estate footprint Source: CBE × cadastre

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
11052C0585/00T002 Flanders 1.0 ha 1 · 2,288 m² 14.7 m · 4 fl.
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Updates 4 events

A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.

2025
23-05-2025
NBB filing Annual accounts filed
fiscal year 2023 · micro
2024
22-10-2024
State Gazette act Director changes
02-08-2024
KBO administration Address struck
Lifecycle & Insolvency Signals 1 events
02-08-2024
KBO administration Address struck
 · Publications in State Gazette ↗
Time machine, BS events + macro context 2021, 2026
COVID lockdownEnergiecrisisECB hikes2021202220232024202520262024-08-02 · KBO administration · Address struck
Macro context
2020-Q2/Q3 COVID lockdown
2022 energy crisis
2023-2024 ECB rate hikes
Legend
Bankruptcy
Interim / reorg
KBO event
Belgisch Staatsblad, acts 1 acts
All acts · 1 updated 1 year ago
2024
22-10-2024 Geoffrey Ejzenberg resigns as director Director changes
  • Geoffrey Ejzenberg, Bestuurder
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Geoffrey Ejzenberg",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": "de_plein_droit_dissolution",
      "subkind": null,
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2024-09-13",
      "evidence_quote": "De bestuurder van Mammoptix BV, Geoffrey Ejzenberg dient per 13 september 2024 zijn ontslag in zoals vermeld aan de andere bestuurder per aangetekend schrijven, alsook verstuurd aan de vennootschap.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": "Antwerpen",
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2024-10-22",
    "filing_date": "2024-10-10",
    "act_kind_objet": "Onderwerp akte:"
  },
  "decisions": [
    {
      "body": "enig_aandeelhouder_schriftelijk",
      "date": "2024-10-10",
      "unanimous": null
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0786.721.270",
    "name_full": "Mammoptix",
    "legal_form": "BV"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Geoffrey Ejzenberg",
    "org_rep_person_name": null,
    "person_role_at_subject": "Bestuurder"
  },
  "co_filed_documents": [],
  "corrected_publication_numac": null
}
Credit advice verdict per customer and amount

Should this customer buy amount X on invoice? Enter the amount and payment terms, you get an instant GREEN/AMBER/RED verdict, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.
AI due-diligence brief Checked AI

Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.

Coming soon
The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works
Company registry (CBE) Crossroads Bank
Activities
Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden32500Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden32500
Primary activity highlighted.
Names & trade names
Legal nameNL Mammoptix
Registration history
  1. 02-08-2024 Address struck
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.
Similar companies Same sector and region · no size comparison possible · 133 of 1,250 with filed accounts
ALDENT BE 0422.727.681 · Antwerpen
ARCA & JUNCO ASSOCIES BE 0424.140.418 · Sint-Lambrechts-Woluwe
BELGIAN OPTICAL SUPPLY BE 0405.585.803 · Kuurne
BELIV BE 0423.599.097 · Haaltert
Berthold Technologies (Belgium) BE 0414.444.871 · Vilvoorde
Source: Belgian State Gazette, CBE, NBB · generated via checked.be · indicative